| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 7 | 2023 | 9 | 3.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2017 | 8 | 2.280 |
Why?
|
| Aortic Aneurysm, Abdominal | 7 | 2017 | 8 | 2.180 |
Why?
|
| Vascular Surgical Procedures | 5 | 2021 | 7 | 2.010 |
Why?
|
| Vascular System Injuries | 2 | 2023 | 2 | 1.390 |
Why?
|
| Stents | 5 | 2017 | 10 | 1.360 |
Why?
|
| Humans | 73 | 2023 | 14537 | 1.110 |
Why?
|
| Aorta | 4 | 2020 | 43 | 1.110 |
Why?
|
| Arterial Occlusive Diseases | 7 | 2015 | 9 | 1.090 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2015 | 6 | 1.060 |
Why?
|
| Peripheral Arterial Disease | 3 | 2021 | 8 | 1.020 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2015 | 3 | 1.000 |
Why?
|
| Arteriosclerosis | 13 | 2020 | 24 | 0.900 |
Why?
|
| General Surgery | 6 | 2009 | 8 | 0.880 |
Why?
|
| Specialties, Surgical | 3 | 2019 | 4 | 0.870 |
Why?
|
| Male | 42 | 2020 | 6754 | 0.820 |
Why?
|
| Ischemia | 6 | 2020 | 19 | 0.810 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 71 | 0.790 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 104 | 0.780 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 239 | 0.750 |
Why?
|
| Confidentiality | 1 | 2020 | 13 | 0.700 |
Why?
|
| Databases, Factual | 1 | 2020 | 64 | 0.690 |
Why?
|
| Contact Tracing | 1 | 2020 | 48 | 0.680 |
Why?
|
| Cost of Illness | 1 | 2021 | 167 | 0.660 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 101 | 0.650 |
Why?
|
| Societies, Medical | 4 | 2019 | 26 | 0.650 |
Why?
|
| Thrombosis | 2 | 2019 | 47 | 0.640 |
Why?
|
| Pandemics | 2 | 2020 | 296 | 0.630 |
Why?
|
| Sutures | 1 | 2018 | 2 | 0.620 |
Why?
|
| Hospital Costs | 1 | 2018 | 4 | 0.610 |
Why?
|
| Medical Audit | 1 | 2018 | 26 | 0.610 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 8 | 0.610 |
Why?
|
| South Africa | 24 | 2021 | 7596 | 0.600 |
Why?
|
| Middle Aged | 32 | 2020 | 3601 | 0.600 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 1 | 0.590 |
Why?
|
| Aged | 21 | 2020 | 1740 | 0.570 |
Why?
|
| Venous Thrombosis | 4 | 2009 | 14 | 0.570 |
Why?
|
| Female | 38 | 2020 | 9103 | 0.550 |
Why?
|
| Developing Countries | 3 | 2020 | 400 | 0.540 |
Why?
|
| Iliac Artery | 2 | 2015 | 2 | 0.530 |
Why?
|
| Adult | 32 | 2020 | 5913 | 0.510 |
Why?
|
| Popliteal Artery | 3 | 2008 | 4 | 0.500 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 3 | 0.500 |
Why?
|
| Treatment Outcome | 8 | 2023 | 889 | 0.500 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 127 | 0.500 |
Why?
|
| Aneurysm, False | 1 | 2015 | 1 | 0.490 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 1 | 0.490 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2006 | 158 | 0.480 |
Why?
|
| Aorta, Abdominal | 2 | 2017 | 4 | 0.480 |
Why?
|
| Suture Techniques | 2 | 2018 | 6 | 0.450 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 26 | 0.430 |
Why?
|
| Leg | 5 | 2019 | 21 | 0.430 |
Why?
|
| Schools, Medical | 3 | 2009 | 8 | 0.410 |
Why?
|
| Education, Medical, Graduate | 2 | 2010 | 4 | 0.410 |
Why?
|
| Carotid Intima-Media Thickness | 5 | 2021 | 108 | 0.410 |
Why?
|
| Risk Assessment | 4 | 2020 | 225 | 0.400 |
Why?
|
| Stroke | 3 | 2020 | 62 | 0.350 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 14 | 0.350 |
Why?
|
| Aortic Rupture | 1 | 2009 | 1 | 0.330 |
Why?
|
| Arteriovenous Fistula | 1 | 2009 | 2 | 0.330 |
Why?
|
| Prospective Studies | 9 | 2018 | 1160 | 0.330 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 5 | 0.330 |
Why?
|
| Education, Medical | 1 | 2009 | 7 | 0.320 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 3 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 37 | 0.310 |
Why?
|
| Traumatology | 1 | 2008 | 1 | 0.310 |
Why?
|
| Hyperlipoproteinemia Type II | 4 | 2004 | 106 | 0.310 |
Why?
|
| Risk Factors | 11 | 2020 | 1475 | 0.300 |
Why?
|
| HIV Seropositivity | 2 | 2009 | 265 | 0.290 |
Why?
|
| Lower Extremity | 2 | 2019 | 10 | 0.280 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2007 | 1 | 0.280 |
Why?
|
| Mass Screening | 3 | 2009 | 245 | 0.280 |
Why?
|
| Varicose Veins | 3 | 2003 | 4 | 0.280 |
Why?
|
| Physician Impairment | 1 | 2006 | 1 | 0.270 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2006 | 1 | 0.270 |
Why?
|
| Heptanoic Acids | 2 | 2004 | 10 | 0.270 |
Why?
|
| Pyrroles | 2 | 2004 | 12 | 0.270 |
Why?
|
| Surgery Department, Hospital | 1 | 2006 | 1 | 0.270 |
Why?
|
| Hospitals, University | 1 | 2006 | 16 | 0.270 |
Why?
|
| Ultrasonography | 9 | 2019 | 77 | 0.260 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 64 | 0.260 |
Why?
|
| Aged, 80 and over | 9 | 2015 | 468 | 0.250 |
Why?
|
| Heterozygote | 3 | 2004 | 43 | 0.250 |
Why?
|
| Atherosclerosis | 1 | 2006 | 100 | 0.250 |
Why?
|
| Venous Insufficiency | 3 | 2002 | 3 | 0.240 |
Why?
|
| Anticholesteremic Agents | 2 | 2004 | 83 | 0.240 |
Why?
|
| Arteries | 3 | 2020 | 18 | 0.240 |
Why?
|
| Methylprednisolone | 1 | 2004 | 6 | 0.230 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 4 | 0.230 |
Why?
|
| Prednisone | 1 | 2004 | 17 | 0.230 |
Why?
|
| Glucocorticoids | 1 | 2004 | 20 | 0.230 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 22 | 0.230 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 29 | 0.220 |
Why?
|
| Blood Pressure | 5 | 2021 | 317 | 0.220 |
Why?
|
| Aircraft | 1 | 2003 | 3 | 0.220 |
Why?
|
| Vascular Stiffness | 2 | 2021 | 41 | 0.220 |
Why?
|
| HIV Infections | 4 | 2014 | 5097 | 0.220 |
Why?
|
| Travel | 1 | 2003 | 21 | 0.220 |
Why?
|
| Carotid Artery, Common | 4 | 2006 | 6 | 0.210 |
Why?
|
| Postoperative Complications | 3 | 2017 | 34 | 0.200 |
Why?
|
| Family Practice | 3 | 2006 | 7 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2015 | 11 | 0.200 |
Why?
|
| Femoral Vein | 1 | 2001 | 1 | 0.190 |
Why?
|
| Triterpenes | 1 | 2001 | 2 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 62 | 0.190 |
Why?
|
| Pulse Wave Analysis | 3 | 2021 | 61 | 0.190 |
Why?
|
| Thrombophlebitis | 2 | 1998 | 2 | 0.190 |
Why?
|
| Plant Extracts | 1 | 2001 | 32 | 0.190 |
Why?
|
| Career Choice | 4 | 2010 | 7 | 0.190 |
Why?
|
| Public Health Administration | 1 | 2021 | 14 | 0.190 |
Why?
|
| Cardiovascular Diseases | 2 | 2004 | 237 | 0.190 |
Why?
|
| Kidney Transplantation | 2 | 1994 | 42 | 0.180 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 43 | 0.180 |
Why?
|
| Physician's Role | 1 | 2020 | 8 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 61 | 0.180 |
Why?
|
| Femoral Artery | 5 | 2014 | 11 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2013 | 4 | 0.180 |
Why?
|
| Case-Control Studies | 6 | 2013 | 480 | 0.170 |
Why?
|
| Limb Salvage | 1 | 2019 | 1 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 27 | 0.160 |
Why?
|
| Public Health | 1 | 2020 | 124 | 0.160 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1998 | 2 | 0.160 |
Why?
|
| Chlamydia Infections | 1 | 1998 | 17 | 0.160 |
Why?
|
| Anticoagulants | 2 | 1998 | 57 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2018 | 1 | 0.150 |
Why?
|
| Appendectomy | 1 | 2018 | 3 | 0.150 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 1998 | 11 | 0.150 |
Why?
|
| Coronary Disease | 2 | 2013 | 17 | 0.150 |
Why?
|
| Mastectomy | 1 | 2018 | 10 | 0.150 |
Why?
|
| Tunica Intima | 4 | 1999 | 6 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 69 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 188 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 30 | 0.150 |
Why?
|
| Health Personnel | 1 | 2020 | 231 | 0.150 |
Why?
|
| Hospitals, Public | 1 | 2018 | 45 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 1998 | 54 | 0.150 |
Why?
|
| Arterial Pressure | 2 | 2020 | 35 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2017 | 21 | 0.150 |
Why?
|
| Kidney | 2 | 1996 | 46 | 0.150 |
Why?
|
| Brachial Artery | 2 | 2021 | 29 | 0.140 |
Why?
|
| Carotid Artery Diseases | 3 | 1993 | 34 | 0.140 |
Why?
|
| Adolescent | 9 | 2015 | 2985 | 0.130 |
Why?
|
| Tunica Media | 2 | 1993 | 3 | 0.130 |
Why?
|
| Aortography | 2 | 2015 | 3 | 0.130 |
Why?
|
| Students, Medical | 2 | 2006 | 14 | 0.130 |
Why?
|
| Prevalence | 5 | 2019 | 1192 | 0.130 |
Why?
|
| Chondrosarcoma | 1 | 1995 | 1 | 0.130 |
Why?
|
| Back Pain | 1 | 1995 | 4 | 0.130 |
Why?
|
| Bone Neoplasms | 1 | 1995 | 6 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 1995 | 18 | 0.130 |
Why?
|
| Africa, Southern | 1 | 2015 | 91 | 0.130 |
Why?
|
| Emergencies | 1 | 2015 | 16 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2015 | 799 | 0.120 |
Why?
|
| Acute Disease | 1 | 2015 | 105 | 0.120 |
Why?
|
| Radiography | 2 | 2009 | 80 | 0.120 |
Why?
|
| Bacteria | 1 | 2015 | 47 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2015 | 54 | 0.120 |
Why?
|
| Adventitia | 1 | 2014 | 2 | 0.120 |
Why?
|
| Vasculitis | 1 | 2014 | 4 | 0.120 |
Why?
|
| Hypertension | 3 | 2019 | 419 | 0.120 |
Why?
|
| Neck Muscles | 1 | 2014 | 2 | 0.120 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2014 | 2 | 0.120 |
Why?
|
| Organ Preservation | 1 | 1994 | 1 | 0.120 |
Why?
|
| Organ Preservation Solutions | 1 | 1994 | 1 | 0.120 |
Why?
|
| Pulsatile Flow | 1 | 1994 | 14 | 0.110 |
Why?
|
| Intermittent Claudication | 1 | 1993 | 1 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2013 | 133 | 0.110 |
Why?
|
| Young Adult | 3 | 2015 | 2498 | 0.110 |
Why?
|
| Angioplasty, Balloon | 2 | 2005 | 2 | 0.100 |
Why?
|
| Radial Artery | 1 | 2012 | 4 | 0.100 |
Why?
|
| Incidence | 4 | 2003 | 685 | 0.100 |
Why?
|
| Intraabdominal Infections | 1 | 2012 | 2 | 0.100 |
Why?
|
| Cilastatin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Imipenem | 1 | 2012 | 6 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 7 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2012 | 15 | 0.100 |
Why?
|
| Carbapenems | 1 | 2012 | 17 | 0.100 |
Why?
|
| Specialization | 2 | 2009 | 8 | 0.100 |
Why?
|
| Carotid Stenosis | 3 | 2005 | 6 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 146 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2013 | 107 | 0.090 |
Why?
|
| Time Factors | 5 | 1998 | 507 | 0.090 |
Why?
|
| Triglycerides | 3 | 2006 | 47 | 0.090 |
Why?
|
| Child, Preschool | 5 | 2002 | 1748 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2010 | 13 | 0.090 |
Why?
|
| Curriculum | 1 | 2010 | 27 | 0.080 |
Why?
|
| Age Factors | 2 | 2019 | 370 | 0.080 |
Why?
|
| Health Resources | 1 | 2010 | 66 | 0.080 |
Why?
|
| Neutrophils | 2 | 2006 | 53 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 293 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2009 | 3 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2008 | 5 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2009 | 18 | 0.080 |
Why?
|
| Syndrome | 1 | 2008 | 19 | 0.080 |
Why?
|
| Comorbidity | 2 | 2006 | 188 | 0.080 |
Why?
|
| Child | 5 | 2002 | 2242 | 0.080 |
Why?
|
| Venous Pressure | 2 | 2002 | 2 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 411 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 3 | 0.070 |
Why?
|
| Constriction | 1 | 2007 | 6 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 106 | 0.070 |
Why?
|
| Infant | 4 | 2002 | 2244 | 0.070 |
Why?
|
| Critical Illness | 2 | 2019 | 44 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 280 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 253 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2006 | 24 | 0.070 |
Why?
|
| E-Selectin | 2 | 2004 | 14 | 0.070 |
Why?
|
| Fees, Medical | 1 | 2006 | 2 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2007 | 57 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2004 | 20 | 0.070 |
Why?
|
| Training Support | 1 | 2006 | 4 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2004 | 25 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 13 | 0.070 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 8 | 0.070 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2006 | 6 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2006 | 3 | 0.070 |
Why?
|
| Faculty, Medical | 1 | 2006 | 4 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2006 | 22 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2007 | 179 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2007 | 101 | 0.070 |
Why?
|
| Income | 1 | 2006 | 85 | 0.070 |
Why?
|
| HIV-1 | 1 | 2014 | 1260 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2003 | 2 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2002 | 370 | 0.060 |
Why?
|
| Wounds, Gunshot | 1 | 1984 | 3 | 0.060 |
Why?
|
| Vasodilation | 1 | 2004 | 7 | 0.060 |
Why?
|
| Italy | 2 | 2002 | 3 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 125 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 96 | 0.050 |
Why?
|
| Phlebotomy | 1 | 2003 | 6 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 2 | 2005 | 2 | 0.050 |
Why?
|
| Sclerotherapy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cholesterol, LDL | 3 | 1999 | 150 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2003 | 105 | 0.050 |
Why?
|
| Animals | 4 | 1998 | 1081 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 2 | 0.050 |
Why?
|
| Reference Values | 4 | 1998 | 64 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 23 | 0.050 |
Why?
|
| Child Welfare | 1 | 2002 | 16 | 0.050 |
Why?
|
| Vascular Diseases | 2 | 1998 | 5 | 0.050 |
Why?
|
| Aging | 2 | 2020 | 109 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1422 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 1994 | 139 | 0.050 |
Why?
|
| Graft Survival | 2 | 1994 | 40 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2003 | 25 | 0.050 |
Why?
|
| Papio | 2 | 1998 | 28 | 0.040 |
Why?
|
| Altruism | 1 | 2020 | 7 | 0.040 |
Why?
|
| Extremities | 1 | 2020 | 5 | 0.040 |
Why?
|
| Professionalism | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 7 | 0.040 |
Why?
|
| Vitamin E | 1 | 1999 | 9 | 0.040 |
Why?
|
| Simvastatin | 1 | 1999 | 10 | 0.040 |
Why?
|
| Global Burden of Disease | 1 | 2019 | 5 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 53 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 50 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 133 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 1998 | 9 | 0.040 |
Why?
|
| Brachiocephalic Trunk | 1 | 1998 | 1 | 0.040 |
Why?
|
| Primate Diseases | 1 | 1998 | 2 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 1998 | 3 | 0.040 |
Why?
|
| Radioisotope Renography | 1 | 1998 | 3 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 253 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 1999 | 19 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 177 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 1997 | 1 | 0.040 |
Why?
|
| Hip Joint | 1 | 1997 | 3 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2002 | 1479 | 0.040 |
Why?
|
| Renal Circulation | 1 | 1996 | 5 | 0.030 |
Why?
|
| Emigration and Immigration | 2 | 2006 | 13 | 0.030 |
Why?
|
| Bandages | 2 | 1997 | 21 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2005 | 31 | 0.030 |
Why?
|
| Organotechnetium Compounds | 1 | 1995 | 1 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1995 | 9 | 0.030 |
Why?
|
| Private Sector | 2 | 2006 | 45 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1995 | 19 | 0.030 |
Why?
|
| Public Sector | 2 | 2006 | 82 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 1995 | 1 | 0.030 |
Why?
|
| Toes | 1 | 1995 | 1 | 0.030 |
Why?
|
| Homozygote | 3 | 2000 | 61 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 66 | 0.030 |
Why?
|
| Recurrence | 3 | 2003 | 29 | 0.030 |
Why?
|
| Vasa Vasorum | 1 | 2014 | 2 | 0.030 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2014 | 3 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1994 | 1 | 0.030 |
Why?
|
| Raffinose | 1 | 1994 | 1 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1994 | 2 | 0.030 |
Why?
|
| Allopurinol | 1 | 1994 | 3 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 1994 | 6 | 0.030 |
Why?
|
| Adenosine | 1 | 1994 | 6 | 0.030 |
Why?
|
| Glutathione | 1 | 1994 | 4 | 0.030 |
Why?
|
| Oleic Acids | 1 | 1993 | 1 | 0.030 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1993 | 1 | 0.030 |
Why?
|
| Sclerosing Solutions | 1 | 1993 | 2 | 0.030 |
Why?
|
| Insulin | 1 | 1994 | 73 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1993 | 26 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 57 | 0.030 |
Why?
|
| Disease Management | 1 | 2013 | 74 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 1993 | 13 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 217 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 10 | 0.020 |
Why?
|
| Manometry | 1 | 2012 | 12 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 42 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 31 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 37 | 0.020 |
Why?
|
| Echocardiography | 1 | 2012 | 100 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2013 | 240 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 563 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 198 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1998 | 8 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1987 | 1 | 0.020 |
Why?
|
| Rectal Diseases | 1 | 1987 | 3 | 0.020 |
Why?
|
| Colitis | 1 | 1987 | 2 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 2 | 1998 | 5 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1987 | 3 | 0.020 |
Why?
|
| Reoperation | 1 | 1987 | 8 | 0.020 |
Why?
|
| Cholesterol, HDL | 2 | 1999 | 32 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1987 | 13 | 0.020 |
Why?
|
| School Admission Criteria | 1 | 2006 | 2 | 0.020 |
Why?
|
| Workplace | 1 | 2006 | 7 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2006 | 8 | 0.020 |
Why?
|
| Sex Factors | 1 | 1987 | 227 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2006 | 28 | 0.020 |
Why?
|
| Politics | 1 | 2006 | 24 | 0.020 |
Why?
|
| Life Style | 1 | 2006 | 86 | 0.020 |
Why?
|
| Aneurysm, Ruptured | 1 | 2005 | 1 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 2005 | 3 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 203 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2005 | 4 | 0.020 |
Why?
|
| Vena Cava Filters | 1 | 2005 | 4 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2005 | 5 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 171 | 0.010 |
Why?
|
| Admitting Department, Hospital | 1 | 1984 | 1 | 0.010 |
Why?
|
| Seasons | 1 | 1984 | 154 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 38 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 45 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1999 | 29 | 0.010 |
Why?
|
| DNA | 1 | 1999 | 73 | 0.010 |
Why?
|
| Dinoprost | 1 | 1999 | 2 | 0.010 |
Why?
|
| F2-Isoprostanes | 1 | 1999 | 2 | 0.010 |
Why?
|
| Disease Progression | 1 | 1999 | 154 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 1999 | 13 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1998 | 2 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1998 | 6 | 0.010 |
Why?
|
| Biomarkers | 1 | 2000 | 327 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 1998 | 1 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 1 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1998 | 2 | 0.010 |
Why?
|
| Angiography | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 10 | 0.010 |
Why?
|
| Calcinosis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 306 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 34 | 0.010 |
Why?
|
| Decision Trees | 1 | 1997 | 3 | 0.010 |
Why?
|
| Embolism | 1 | 1997 | 4 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1997 | 12 | 0.010 |
Why?
|
| Aspirin | 1 | 1997 | 15 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1997 | 26 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1997 | 29 | 0.010 |
Why?
|
| Hippurates | 1 | 1996 | 2 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1996 | 3 | 0.010 |
Why?
|
| Hematocrit | 1 | 1996 | 6 | 0.010 |
Why?
|
| Cause of Death | 1 | 1998 | 221 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1996 | 32 | 0.010 |
Why?
|
| Amputation | 1 | 1995 | 4 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1994 | 10 | 0.010 |
Why?
|
| Glycated Hemoglobin A | 1 | 1994 | 24 | 0.010 |
Why?
|
| Cholesterol | 1 | 1994 | 38 | 0.010 |
Why?
|
| Duodenoscopy | 1 | 1993 | 1 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1993 | 3 | 0.010 |
Why?
|
| Epinephrine | 1 | 1993 | 9 | 0.010 |
Why?
|
| Injections | 1 | 1993 | 31 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1993 | 12 | 0.010 |
Why?
|
| Gemfibrozil | 1 | 1992 | 1 | 0.010 |
Why?
|
| Bezafibrate | 1 | 1992 | 2 | 0.010 |
Why?
|
| Cats | 1 | 1992 | 3 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 25 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 2 | 0.010 |
Why?
|
| Plethysmography | 1 | 1992 | 5 | 0.010 |
Why?
|
| Cysts | 1 | 1987 | 2 | 0.000 |
Why?
|
| Mucus | 1 | 1987 | 2 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1987 | 63 | 0.000 |
Why?
|
| Rectum | 1 | 1987 | 22 | 0.000 |
Why?
|